Results 191 to 200 of about 360,530 (300)

Review of current best practice in radiation oncology for older adults with cancer: Updates from the International Society of Geriatric Oncology (SIOG) Task Force

Lucinda Morris, Niluja Thiruthaneeswaran, Anita O'Donovan, Noam VanderWalde, Anthea Cree, Surbhi Grover, Stefan Starup Jeppesen, Richard Simcock   +7 more
openalex   +1 more source

EDTA‐Functionalized Nanoscale Metal–Organic Framework for Onco‐Cardiology via Radiochemotherapy Synergy and Spatiotemporally Matched Iron Chelation

Advanced Science, EarlyView.
Doxorubicin (DOX)‐induced cardiotoxicity is a major limitation to its broader clinical application, while cardioprotective interventions often risk reducing the anticancer efficacy of DOX. To address these challenges, this work constructs an EDTA‐functionalized metal–organic framework that enhances tumor therapy and provides efficient cardioprotection ...
Daojing Yuan, Liyang Tian, Luwen Zhuang, Yongyu Liang, Lingfei Chen, Xuetao Wang, Yanli Li, Xiyong Yu, Teng Gong   +8 more
wiley   +1 more source

Editorial: Artificial intelligence in radiology and radiation oncology. [PDF]

Front Radiol
Ng CKC, Leung VWS.
europepmc   +1 more source

Biomimetic Cell Membrane‐Coated MOFs System for Targeted Cancer Therapy

Advanced Science, EarlyView.
Biomimetic MOF‐based drug delivery nanoplatforms synthesized using liposomes or cell membranes as camouflage for multiple cancer therapeutics. ABSTRACT The integration of metal‐organic frameworks (MOFs) with cell membrane coatings has emerged as a revolutionary strategy to enhance the therapeutic efficacy of cancer nanomedicine.
Qilu Wu, Jia Song Deon Chon, Yuxiao Feng, Kang Liang, Shiming Li, Can Yang Zhang, Jun Ge   +6 more
wiley   +1 more source

Correction: Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversight. [PDF]

Front Oncol
Dinç U, Sarkar J, Schubert P, Semrau S, Weissmann T, Karius A, Brand J, Axer BN, Gomaa A, Stephan P, Sheth I, Beirami S, Schwarz A, Gaipl U, Frey B, Bert C, Corradini S, Fietkau R, Putz F.   +18 more
europepmc   +1 more source

Promoter Hypermethylation‐Induced Silencing of FXYD1 Drives Breast Cancer Metastasis via DDX5‐Mediated Wnt/β‐Catenin Pathway Activation

Advanced Science, EarlyView.
This study identifies FXYD1 as an epigenetically silenced tumor suppressor in breast cancer. DNA methylation turns off the gene FXYD1 in breast cancer, and low levels predict worse outcomes. Restoring FXYD1 limits breast cancer cells proliferation and metastasis. In the nucleus, FXYD1 recruits the E3 ligase MAEA to K63‐ubiquitinate DDX5 for proteasomal
Ping Wen, Fanli Qu, Long Wang, Qing Shao, Sisi Li, Yang Qin, Dongping Jiang, Senmiao Zhang, Jiangdong Sui, Guanwen Wang, Ningning Zhang, Xiaohua Zeng   +11 more
wiley   +1 more source

Setting Up a Pediatric Radiation Oncology Program in Sub-Saharan Africa: Report From Nigeria. [PDF]

Adv Radiat Oncol
Joseph A, Oladipo A, Agbakwuru CI, Fagbemide O, Obianyor C, Kotkat A, Adedewe N, Mangongolo BM, Badejoko K, Saba B, Akinsete A, Habeebu M.   +11 more
europepmc   +1 more source

The Management of Nasal Cavity and Paranasal Sinuses Cancers: Experience of Radiation Oncology Department of Mohamed VI Teaching Hospital of Marrakech

Youness El-Khadir, Ghita Hadraoui, Rokkaya Iharti, Mouna Darfaoui, Samir Barkiche, N. Oumghar, Abdelhamid El Omrani, Mouna Khouchani   +7 more
openalex   +1 more source

Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy

Advanced Science, EarlyView.
Cancer immunotherapy faces challenges in predicting treatment responses and understanding resistance mechanisms. Artificial intelligence (AI) and machine learning (ML) offer powerful solutions for cancer immunotherapy in patient stratification, biomarker discovery, treatment strategy optimization, and foundation model development.
Xinchao Wu, Mengtao Sun, Lusheng Li, Jieqiong Wang, Shibiao Wan   +4 more
wiley   +1 more source

Correction to: Analysis and stress-test of the spatial accessibility to German radiation oncology centers. [PDF]

Strahlenther Onkol
Straube C, Medenwald D, Holthaus T.
europepmc   +1 more source